The disease diabetes mellitus occurs in two different forms
– juvenile or adult-onset. In either
case, the source of the illness is lack of or reduced production of the hormone
insulin (see image below) whose role is to enhance the uptake of glucose
circulating in the blood by tissue cells, especially adipose and skeletal muscle. Insulin (as seen below) is referred to as a
globular protein
Insulin is normally produced by specialized beta cells
resident in the Islets of Langerhans within the pancreas. It has been established that juvenile
diabetes is an auto-immune disease in which the immune system of the patient
attacks these beta cells.
Adult-onset diabetes, on the other hand, has a strong association with
obesity.
This inability to transfer glucose to tissue cells where it
is utilized for energy, leads to high concentrations of glucose in the blood
(hyperglycemia). Over a prolonged period
of time, this hyperglycemic state results in very serious and ultimately
life-threatening complications including blindness, impaired kidney function, cardiovascular
issues leading to heart trouble and leaving victims prone to amputation. These deleterious side effects arise as the
excess glucose in the blood reacts with proteins in various tissues throughout
the body – this biochemical reaction is referred to as glycosylation.
Once the cause of diabetes was discovered, it was realized
that an obvious therapeutic approach is to give the patient insulin from an
external source. Before the advent of
DNA recombinant technology, patients were given insulin harvested from cow
pancreas (bovine insulin). Bovine and
human insulin are close enough in structure to allow bovine insulin to have an
efficacious effect. Currently, of
course, human insulin is readily available.
Over many years of treating diabetic patients with human
insulin, it was realized that periodic administration of insulin is not
comparable to the body’s finely tuned regulation of insulin production so as to
maintain optimal levels of blood glucose.
In response to this deficit, a technology arose to employ the use of an
insulin pump in order to maintain a steady stream of insulin along with careful
monitoring of blood glucose levels. In
addition, considerable emphasis has been placed on nutrition, exercise and
weight control especially in regard to adult-onset diabetes.
Another important tool in the treatment of diabetes is the
so-called A1C test. This test provides
information as to the average level of blood glucose over a 3-month time span;
it is also referred to as the glycohemoglobin test. This test measures the amount of glycosylated
hemoglobin. Hemoglobin is the
specialized protein in red blood cells that is designed to carry oxygen to the
tissues. This protein reacts with excess
glucose in the blood. Since red blood
cells are recycled by the body over a 3-month period, the test provides
information about the average level of glucose in the blood over this period of
time. The result of this test is
reported as a percentage. The normal
value is about 5.7%. The higher the
percentage, the higher the blood glucose level has been over the past 3 months.
The A1C test is an important tool in determining the
efficacy of treatment for diabetic patients.
No comments:
Post a Comment